Safadi, Rifaat

Publishing since 1994 (Senior)

Has published 93 publications in 16 years

Number of publications published per year by Safadi, Rifaat. (Source : PubMed)

Distribution of publications types for Safadi, Rifaat. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ginsburg I, Koren E, Horani A, Mahamid M, Doron S, Muhanna N, Amer J, Safadi R. Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes.  Clin. Exp. Immunol.  2009;157;1  
•  Muhanna N, Doron S, Wald O, Horani A, Eid A, Pappo O, Friedman SL, Safadi R. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.  Hepatology  2008;48;3  
•  Mizrahi M, Lalazar G, Horwich Y, Adar T, Safadi R. [Benign recurrent intrahepatic cholestasis type-II--a rare cause of direct hyperbilirubinemia exacerbations with hepatic fibrosis]  Harefuah  2008;147;5  
•  Higazi AA, El-Haj M, Melhem A, Horani A, Pappo O, Alvarez CE, Muhanna N, Friedman SL, Safadi R. Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis.  Clin. Exp. Immunol.  2008;152;1  
•  Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, Keinan-Boker L, Broide E, Ackerman Z, Kaluski DN, Lev B, Shouval D. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity.  J. Hepatol.  2007;47;4  
•  Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y. Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution.  Int. Immunol.  2007;19;8  
•  Heyman SN, Reches A, Safadi R, Cohen R. [Introduction of a brief Problem-Based-Learning (PBL) experience in traditional medical faculty curriculum]  Harefuah  2007;146;6  
•  Muhanna N, Horani A, Doron S, Safadi R. Lymphocyte-hepatic stellate cell proximity suggests a direct interaction.  Clin. Exp. Immunol.  2007;148;2  
•  Horani A, Muhanna N, Pappo O, Melhem A, Alvarez CE, Doron S, Wehbi W, Dimitrios K, Friedman SL, Safadi R. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.  Am. J. Physiol. Gastrointest. Liver Physiol.  2007;292;2  
•  Galun E, Terrault NA, Eren R, Zauberman A, Nussbaum O, Terkieltaub D, Zohar M, Buchnik R, Ackerman Z, Safadi R, Ashur Y, Misrachi S, Liberman Y, Rivkin L, Dagan S. Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.  J. Hepatol.  2007;46;1  

[ See timeline ] [ See all publications ]